Lekha Gupta Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果